Researchers Find Potential New Target for Mesothelioma Treatment
A group of researchers at NYU are focusing on the presence of Eprin B2 in patients with malignant pleural mesothelioma
A group of researchers at NYU are focusing on the presence of Eprin B2 in patients with malignant pleural mesothelioma